Patents by Inventor Yasuhiro MATSUNAWA

Yasuhiro MATSUNAWA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TERIPARATIDE-CONTAINING LIQUID PHARMACEUTICAL COMPOSITION HAVING EXCELLENT STABILITY
    Publication number: 20210205418
    Abstract: According to the present invention, a liquid pharmaceutical preparation containing teriparatide or a salt thereof having excellent physical properties, the liquid pharmaceutical preparation containing teriparatide or a salt thereof, and at least one or more members of inorganic salts and/or organic salts is provided.
    Type: Application
    Filed: March 19, 2021
    Publication date: July 8, 2021
    Applicant: ASAHI KASEI PHARMA CORPORATION
    Inventors: Kohei Miyabe, Takahiro Yamaguchi, Yasuhiro Matsunawa, Narumi Watanabe
  • TERIPARATIDE-CONTAINING LIQUID PHARMACEUTICAL COMPOSITION HAVING EXCELLENT PHARMACOKINETICS AND/OR SAFETY
    Publication number: 20200289622
    Abstract: A liquid pharmaceutical preparation for subcutaneous administration in human containing 28.2 ?g of teriparatide or a salt thereof (Component 1) in a unit dose in terms of teriparatide, wherein the Component 1 concentration is from 80 to 240 ?g/mL. This liquid pharmaceutical preparation is excellent in the viewpoint of pharmacokinetics.
    Type: Application
    Filed: September 20, 2018
    Publication date: September 17, 2020
    Applicant: ASAHI KASEI PHARMA CORPORATION
    Inventors: Kohei MIYABE, Atsushi OSE, Yuki SATO, Toshiyuki KODAMA, Yasuhiro MATSUNAWA, Hikaru YAMAMOTO
  • TERIPARATIDE-CONTAINING LIQUID PHARMACEUTICAL COMPOSITION HAVING EXCELLENT STABILITY
    Publication number: 20200289621
    Abstract: According to the present invention, a liquid pharmaceutical preparation containing teriparatide or a salt thereof having excellent physical properties, the liquid pharmaceutical preparation containing teriparatide or a salt thereof, and at least one or more members of inorganic salts and/or organic salts is provided.
    Type: Application
    Filed: September 20, 2018
    Publication date: September 17, 2020
    Applicant: ASAHI KASEI PHARMA CORPORATION
    Inventors: Kohei MIYABE, Takahiro YAMAGUCHI, Yasuhiro MATSUNAWA, Narumi WATANABE